酮洛芬前体药物经皮吸收的选择性及代谢机理研究
项目介绍
AI项目解读
基本信息
- 批准号:39970880
- 项目类别:面上项目
- 资助金额:11.0万
- 负责人:
- 依托单位:
- 学科分类:H3408.药剂学
- 结题年份:2002
- 批准年份:1999
- 项目状态:已结题
- 起止时间:2000-01-01 至2002-12-31
- 项目参与者:朱全刚; 范国荣; 孙华君; 蔡溱;
- 关键词:
项目摘要
Transdermal drug delivery system is an increasing active field of drug preparation study. Skin is the mainly barrier of transdermal penetration, and is rich in enzyme activity, so the study on skin metabolism of drug is very important to the study on percutaneous absorption. The stratum corneum, the rate-limiting barrier to percutaneous absorption, is made up of keratin and ceramides, which could potentially provide a chiral environment. Differential binding of enantiomers to keratin or interactions with ceramide may give rise to differences in the permeation profiles of enantiomers, and have influence on the clinical effect of enantiomer. Therefore the transdermal delivery of enantiomers of chiral species is an increasing active and promising field. .Ketoprofen, a nonsteroidal anti-inflammatory drug, is used as model drug for synthesizing a series of ester prodrugs in this paper. The characteristic of percutaneous absorption and mechanism of skin esterase metabolism were discussed. Ketoprofen and its ester prodrug were separated by HPLC using α-acid glycoprotrin column. Excised skin was prepared by surgical excision and enzyme digestion. Side-by-side diffusion cells were used for in vitro permeation studies using whole thickness skin, stripped skin and dermis as permeation membrane, so the active site of skin metabolism and the stereoselective characteristic were determined. HaCaT cell line derived from human abdominal keratinocyte was used to study the dynamic characteristic of prodrug metabolism, and the type of carboxylesterase in HaCaT cell was also clarified. The in situ perfused pig ear or rabbit ear model for percutaneous absorption were established, methyl salicylate and ketoprofen isopropyl ester were used for validating these model, and the difference between biotransformation rates were compared..The determination of ketoprofen and its prodrug in cell culture fluid, skin homogenate and receiver solutin of permeation was not affected by impurity such as protein. The HPLC method was accurate, and meet for analysis. Ketoprofen ester prodrug can be hydrolyzed in infant and adult epidermis homogenate, New Zealand rabbit epidermis homogenate, weanling pig epidermis homogenate, and SD rat epidermis homogenate. The hydrolysis reaction has stereoselectivity at the beginning except SD rat homogenate, the main product is R-ketoprofen. Ketoprofen esters can be metabolized to ketoprofen in in situ skin during percutaneous penetration process in HuangShan monkey skin, BABL/C nude mouse skin and SD rat skin. Skin esterase metabolism mainly develops in the epidermis. In the HaCaT cell culture system, the metabolism of ketoprofen ester also has stereoselectivity, especially ketoprofen isopropyl ester, their product are mainly R-ketoprofen. HaCaT cell can express human carboxylesterase-2. Two in situ models of percutaneous absorption were established based on the ear vein perfusion. One model is about rabbit ear, the influences of protein concentration, flow rate of buffer and temperature were determined, methyl salicylate was applied to this model. Another model is about pig ear, its biological activity can be kept during seven hours, methyl salicylate and ketoprofen isopropyl ester were metabolized to salicy acid and ketoprofen during percutaneous penetration, Azone has enhancive effect on permeation and metabolism of methyl salicylate..The main metabolite of ketoprofen ester in HaCaT cell homogenate and human skin homogenate is R-ketoprofen, especially ketoprofen isopropyl ester, this may be due to the selectivity of carboxylesterase. R-ketoprofen does not inhibit the activity of cyclooxygenase, but has better analgesic effect, may become a novel drug in the treatment of toothache. So HaCaT cell is a better carrier for synthesizing chiral drug by biological method, and is a novel thought for separating enantiomers. Along with the study on expression and purifying of carboxylesteras in HaCaT cell, a novel biological method for synthesizing chiral drug will be acquired, and the mechanism about setereoselective hydrolysis in
以酮洛芬衍生物KPD-02为模型药物,探讨手性前体经皮吸收的立体选择性差异及皮肤酯酶的生物转化作用。在KPD-02手性拆分及纯对映体制备的基础上,考察经皮吸收过程中的手性特征及代谢机理,建立在体经皮吸收(幼猪耳部皮肤)有渗透/代谢模型,为药物透皮吸收制恋难兄坪涂⑻峁┓椒ㄖ傅己图际踅杓
结项摘要
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(2)
会议论文数量(0)
专利数量(0)
酮洛芬前体药物皮肤渗透代谢的立体选择性研究
- DOI:--
- 发表时间:--
- 期刊:中国药科大学学报
- 影响因子:--
- 作者:朱全刚;胡晋红;奚炜;刘少明;孙华君
- 通讯作者:孙华君
皮肤羧酸酯酶代谢的立体选择性
- DOI:--
- 发表时间:--
- 期刊:药学学报
- 影响因子:--
- 作者:朱全刚;胡晋红;曾华武
- 通讯作者:曾华武
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi || "--"}}
- 发表时间:{{ item.publish_year || "--" }}
- 期刊:{{ item.journal_name }}
- 影响因子:{{ item.factor || "--"}}
- 作者:{{ item.authors }}
- 通讯作者:{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.authors }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.authors }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.authors }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.authors }}
数据更新时间:{{ patent.updateTime }}
其他文献
酮洛芬及其异丙酯对HaCaT细胞构建的组织工程皮肤的渗透作用
- DOI:--
- 发表时间:--
- 期刊:药学学报
- 影响因子:--
- 作者:徐燕丰;胡晋红;朱全刚;徐术;潘勇华
- 通讯作者:潘勇华
影响中药饮片质量的因素
- DOI:--
- 发表时间:--
- 期刊:中国药学杂志
- 影响因子:--
- 作者:檀密艳;王忠壮;全山丛;万鲲;胡晋红
- 通讯作者:胡晋红
表面活性剂对高水溶性药物阿魏酸
- DOI:--
- 发表时间:--
- 期刊:药学服务与研究, 2005, 5(2):153-156
- 影响因子:--
- 作者:苏华;胡晋红;李凤前
- 通讯作者:李凤前
木属药用植物的药理活性研究
- DOI:--
- 发表时间:--
- 期刊:中国药学杂志
- 影响因子:--
- 作者:万鲲;王忠壮;胡晋红
- 通讯作者:胡晋红
川芎挥发油对氟比洛芬渗透离体大
- DOI:--
- 发表时间:--
- 期刊:药学服务与研究, 2006, 6(6): 413-416
- 影响因子:--
- 作者:张立超;高丽红;胡晋红;严翠霞
- 通讯作者:严翠霞
其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi || "--" }}
- 发表时间:{{ item.publish_year || "--"}}
- 期刊:{{ item.journal_name }}
- 影响因子:{{ item.factor || "--" }}
- 作者:{{ item.authors }}
- 通讯作者:{{ item.author }}
内容获取失败,请点击重试
查看分析示例
此项目为已结题,我已根据课题信息分析并撰写以下内容,帮您拓宽课题思路:
AI项目摘要
AI项目思路
AI技术路线图
请为本次AI项目解读的内容对您的实用性打分
非常不实用
非常实用
1
2
3
4
5
6
7
8
9
10
您认为此功能如何分析更能满足您的需求,请填写您的反馈:
胡晋红的其他基金
阻断Ca2+介导的PAR-2信号通路抗特应性皮炎慢性瘙痒的新靶点研究
- 批准号:81173130
- 批准年份:2011
- 资助金额:14.0 万元
- 项目类别:面上项目
TRAIL作为治疗银屑病新的药物作用靶点
- 批准号:30873128
- 批准年份:2008
- 资助金额:35.0 万元
- 项目类别:面上项目
药物透皮吸收的皮肤免疫屏障研究
- 批准号:30572269
- 批准年份:2005
- 资助金额:28.0 万元
- 项目类别:面上项目
肝星状细胞靶向给药系统的研究
- 批准号:30371701
- 批准年份:2003
- 资助金额:20.0 万元
- 项目类别:面上项目
利用组织工程皮肤研究药物透皮吸收及代谢
- 批准号:30271553
- 批准年份:2002
- 资助金额:7.0 万元
- 项目类别:面上项目
相似国自然基金
{{ item.name }}
- 批准号:{{ item.ratify_no }}
- 批准年份:{{ item.approval_year }}
- 资助金额:{{ item.support_num }}
- 项目类别:{{ item.project_type }}
相似海外基金
{{
item.name }}
{{ item.translate_name }}
- 批准号:{{ item.ratify_no }}
- 财政年份:{{ item.approval_year }}
- 资助金额:{{ item.support_num }}
- 项目类别:{{ item.project_type }}